Orla M. Finucane

2.3k citations

16 papers · 1.9k indexed · 2 hit papers · h-index 14

Molecular Biology top 10%
Physiology top 5%
Epidemiology top 10%
Immunology top 5%
Neurology top 2%

Co-authors: Helen M. Roche Marina A. Lynch Aoibheann M. McMorrow Ruth M. Connaughton Fiona C. McGillicuddy Ana Rubio‐Araiz Clare M. Reynolds Luke O'neill
Topics: Adipokines, Inflammation, and Metabolic Diseases (7 papers)Adipose Tissue and Metabolism (4 papers)Inflammasome and immune disorders (4 papers)
Cited by: Biological Psychiatry Neurology Physiology
Journals: Circulation PLoS ONE Diabetes
Partner nations: Ireland Canada United Kingdom

In The Last Decade

Orla M. Finucane

15 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice

2016 442 citations Karen Bryson, Orla M. Finucane et al. Brain Behavior and Immunity profile →
Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies

2013 412 citations Orla M. Finucane, Ruth M. Connaughton et al. Frontiers in Endocrinology profile →

Peers

Countries citing papers authored by Orla M. Finucane

Since Specialization

Citations

This map shows the geographic impact of Orla M. Finucane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orla M. Finucane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orla M. Finucane more than expected).

Fields of papers citing papers by Orla M. Finucane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orla M. Finucane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orla M. Finucane. The network helps show where Orla M. Finucane may publish in the future.

Co-authorship network of co-authors of Orla M. Finucane

This figure shows the co-authorship network connecting the top 25 collaborators of Orla M. Finucane. A scholar is included among the top collaborators of Orla M. Finucane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orla M. Finucane. Orla M. Finucane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Dietary substitution of SFA with MUFA within high-fat diets attenuates hyperinsulinaemia and pancreatic islet dysfunction 2020 ·British Journal Of Nutrition ·Jessica C. Ralston,Marie‐Sophie Nguyen‐Tu,Claire L. Lyons,Aoife A. Cooke,Aoife M. Murphy,(unknown),Orla M. Finucane,Fiona C. McGillicuddy,Guy A. Rutter,Helen M. Roche	11
2	The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages 2019 ·Scientific Reports ·Orla M. Finucane,Jamie Sugrue,Ana Rubio‐Araiz,Marie‐Victoire Guillot‐Sestier,Marina A. Lynch	103
3	Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of β-amyloid 2018 ·Journal of Neuroinflammation ·Ana Rubio‐Araiz,Orla M. Finucane,(unknown),Marina A. Lynch	90
4	FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation 2017 ·Journal of Neuroimmune Pharmacology ·Róisín M. McManus,Orla M. Finucane,Mieszko M. Wilk,Kingston H. G. Mills,Marina A. Lynch	26
5	Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice 2017 ·Brain Behavior and Immunity ·Ross Holland,Allison McIntosh,Orla M. Finucane,Virginia Mela,Ana Rubio‐Araiz,George A. Timmons,Sarah A. McCarthy,Yurii K. Gun’ko,Marina A. Lynch	164
6	Pancreatic islet dysfunction is partially attenuated by replacement of dietary saturated fatty acids with monounsaturated fatty acids 2017 ·Proceedings of The Nutrition Society ·Jessica C. Ralston,(unknown),Claire L. Lyons,(unknown),Aoife A. Cooke,(unknown),Orla M. Finucane,Guy A. Rutter,Helen M. Roche	1
7	Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 micebreakdown → 2016 ·Brain Behavior and Immunity ·(unknown),(unknown),Karen Bryson,Orla M. Finucane,Caroline M. Larkin,Evanna L. Mills,Avril A. B. Robertson,Matthew A. Cooper,Luke O'neill,Marina A. Lynch	442
8	A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome‐mediated inflammation and improving insulin signaling 2016 ·Molecular Nutrition & Food Research ·(unknown),(unknown),(unknown),(unknown),Alice B. Nongonierma,Deirdre Keane,(unknown),(unknown),Claire L. Lyons,Fiona C. McGillicuddy,Orla M. Finucane,Brian A. Murray,Philip M. Kelly,Lorraine Brennan,Richard J. Fitzgerald,Helen M. Roche	25
9	High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets 2016 ·Circulation ·M. O'Reilly,Eugène Dillon,(unknown),Orla M. Finucane,Aoibheann M. McMorrow,Aoife M. Murphy,Claire L. Lyons,Daniel Jones,Miriam Ryan,Michael J. Gibney,Eileen R. Gibney,Lorraine Brennan,Margarita de la Llera Moya,Muredach P. Reilly,Helen M. Roche,Fiona C. McGillicuddy	50
10	Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity 2015 ·Diabetes ·Orla M. Finucane,Claire L. Lyons,Aoife M. Murphy,Clare M. Reynolds,Rut Klinger,(unknown),Aoife A. Cooke,Rebecca C. Coll,Liam McAllan,Kanishka N. Nilaweera,M. O'Reilly,Audrey Tierney,Melissa J. Morine,Juan F. Alcalá‐Díaz,José López‐Miranda,Darran P. O’Connor,Luke O'neill,Fiona C. McGillicuddy,Helen M. Roche	233
11	Interactions between differential fatty acids and inflammatory stressors—impact on metabolic health 2014 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Aoife M. Murphy,Claire L. Lyons,Orla M. Finucane,Helen M. Roche	22
12	Macrophage Migration Inhibitory Factor Deficiency Ameliorates High-Fat Diet Induced Insulin Resistance in Mice with Reduced Adipose Inflammation and Hepatic Steatosis 2014 ·PLoS ONE ·Orla M. Finucane,Clare M. Reynolds,Fiona C. McGillicuddy,Karen A. Harford,Martine C. Morrison,John A. Baugh,Helen M. Roche	45
13	Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategiesbreakdown → 2013 ·Frontiers in Endocrinology ·(unknown),Orla M. Finucane,Ruth M. Connaughton,Aoibheann M. McMorrow,Helen M. Roche	412
14	Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice 2013 ·American Journal of Physiology-Endocrinology and Metabolism ·Fiona C. McGillicuddy,Clare M. Reynolds,Orla M. Finucane,(unknown),Karen A. Harford,(unknown),Domenico Sergi,Lynda M. Williams,Kingston H. G. Mills,Helen M. Roche	27
15	Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance 2012 ·Proceedings of The Nutrition Society ·Orla M. Finucane,Clare M. Reynolds,Fiona C. McGillicuddy,Helen M. Roche	61
16	Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells—implications for diet‐induced insulin resistance 2012 ·Molecular Nutrition & Food Research ·Clare M. Reynolds,Fiona C. McGillicuddy,Karen A. Harford,Orla M. Finucane,Kingston H. G. Mills,Helen M. Roche	138

About Orla M. Finucane

Orla M. Finucane is a scholar working on Biological Psychiatry, Immunology and Neurology, having authored 16 papers that have together received 1.9k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Adipose Tissue and Metabolism (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Biological Psychiatry (197 citations), Neurology (397 citations) and Physiology (591 citations). Orla M. Finucane has collaborated with scholars based in Ireland, Canada and United Kingdom. Frequent co-authors include Helen M. Roche, Marina A. Lynch, Aoibheann M. McMorrow, Ruth M. Connaughton, Fiona C. McGillicuddy, Ana Rubio‐Araiz, Clare M. Reynolds, Luke O'neill, Caroline M. Larkin and Karen Bryson. Their work appears in journals such as Circulation, PLoS ONE and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact